Global & Disaster Medicine

Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said the FDA has cleared the emergency use of its therapy to treat acute radiation exposure in a nuclear event. » Nuke


This entry was posted on Wednesday, May 2nd, 2018 at 3:58 am and is filed under . You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Log in here with your UTAD account.